Tumor Infiltrating Lymphocytes Reemerge as Potential Melanoma Option

(MedPage Today) -- PARIS -- More than twice as many patients with previously treated advanced melanoma remained progression-free at 6 months when they received their own tumor infiltrating lymphocytes (TILs) instead of immunotherapy, a randomized...
Source: MedPage Today Dermatology - Category: Dermatology Source Type: news